| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.0038 | 1 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.001 | 1 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.00082 | 1 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.00074 | 1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.00054 | 1 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.00064 | 1 |